NeuroBo Pharmaceuticals to Participate in Investor Conferences in November

Provided By PR Newswire

Last update: Nov 13, 2024

CAMBRIDGE, Mass., Nov. 13, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced participation in the following investor conferences in November: